chr10-95637470-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002860.4(ALDH18A1):​c.304-34A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.701 in 1,611,086 control chromosomes in the GnomAD database, including 397,402 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). There are indicators that this mutation may affect the branch point..

Frequency

Genomes: 𝑓 0.66 ( 33725 hom., cov: 30)
Exomes 𝑓: 0.70 ( 363677 hom. )

Consequence

ALDH18A1
NM_002860.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -0.00700

Publications

13 publications found
Variant links:
Genes affected
ALDH18A1 (HGNC:9722): (aldehyde dehydrogenase 18 family member A1) This gene is a member of the aldehyde dehydrogenase family and encodes a bifunctional ATP- and NADPH-dependent mitochondrial enzyme with both gamma-glutamyl kinase and gamma-glutamyl phosphate reductase activities. The encoded protein catalyzes the reduction of glutamate to delta1-pyrroline-5-carboxylate, a critical step in the de novo biosynthesis of proline, ornithine and arginine. Mutations in this gene lead to hyperammonemia, hypoornithinemia, hypocitrullinemia, hypoargininemia and hypoprolinemia and may be associated with neurodegeneration, cataracts and connective tissue diseases. Alternatively spliced transcript variants, encoding different isoforms, have been described for this gene. [provided by RefSeq, Jul 2008]
ALDH18A1 Gene-Disease associations (from GenCC):
  • cutis laxa, autosomal dominant 3
    Inheritance: AD, SD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • ALDH18A1-related de Barsy syndrome
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, G2P, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • autosomal recessive complex spastic paraplegia type 9B
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • P5CS deficiency
    Inheritance: SD Classification: DEFINITIVE Submitted by: ClinGen, Illumina
  • hereditary spastic paraplegia 9A
    Inheritance: AD, SD Classification: MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics
  • autosomal dominant complex spastic paraplegia type 9B
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal dominant cutis laxa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
This position, referring to a specific DNA site, is a probable branch point but is likely benign (scored 2 / 10, using the threshold of <=3). The score ranges from 0 to 10, with values ≤3 considered benign and >5 classified as pathogenic. Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 10-95637470-T-C is Benign according to our data. Variant chr10-95637470-T-C is described in ClinVar as Benign. ClinVar VariationId is 258826.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.722 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ALDH18A1NM_002860.4 linkc.304-34A>G intron_variant Intron 3 of 17 ENST00000371224.7 NP_002851.2 P54886-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ALDH18A1ENST00000371224.7 linkc.304-34A>G intron_variant Intron 3 of 17 1 NM_002860.4 ENSP00000360268.2 P54886-1
ALDH18A1ENST00000371221.3 linkc.304-34A>G intron_variant Intron 3 of 17 1 ENSP00000360265.3 P54886-2
ALDH18A1ENST00000483788.1 linkn.496-34A>G intron_variant Intron 3 of 4 3

Frequencies

GnomAD3 genomes
AF:
0.663
AC:
100605
AN:
151806
Hom.:
33718
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.564
Gnomad AMI
AF:
0.732
Gnomad AMR
AF:
0.689
Gnomad ASJ
AF:
0.683
Gnomad EAS
AF:
0.742
Gnomad SAS
AF:
0.604
Gnomad FIN
AF:
0.639
Gnomad MID
AF:
0.656
Gnomad NFE
AF:
0.717
Gnomad OTH
AF:
0.656
GnomAD2 exomes
AF:
0.688
AC:
170300
AN:
247366
AF XY:
0.687
show subpopulations
Gnomad AFR exome
AF:
0.561
Gnomad AMR exome
AF:
0.699
Gnomad ASJ exome
AF:
0.689
Gnomad EAS exome
AF:
0.764
Gnomad FIN exome
AF:
0.650
Gnomad NFE exome
AF:
0.716
Gnomad OTH exome
AF:
0.688
GnomAD4 exome
AF:
0.705
AC:
1028309
AN:
1459160
Hom.:
363677
Cov.:
40
AF XY:
0.702
AC XY:
509859
AN XY:
725900
show subpopulations
African (AFR)
AF:
0.551
AC:
18440
AN:
33438
American (AMR)
AF:
0.700
AC:
31211
AN:
44612
Ashkenazi Jewish (ASJ)
AF:
0.698
AC:
18227
AN:
26124
East Asian (EAS)
AF:
0.705
AC:
27963
AN:
39682
South Asian (SAS)
AF:
0.625
AC:
53858
AN:
86166
European-Finnish (FIN)
AF:
0.653
AC:
34094
AN:
52192
Middle Eastern (MID)
AF:
0.675
AC:
3878
AN:
5748
European-Non Finnish (NFE)
AF:
0.719
AC:
798438
AN:
1110866
Other (OTH)
AF:
0.699
AC:
42200
AN:
60332
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
14719
29438
44156
58875
73594
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19874
39748
59622
79496
99370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.663
AC:
100656
AN:
151926
Hom.:
33725
Cov.:
30
AF XY:
0.659
AC XY:
48966
AN XY:
74264
show subpopulations
African (AFR)
AF:
0.563
AC:
23314
AN:
41384
American (AMR)
AF:
0.689
AC:
10513
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.683
AC:
2367
AN:
3468
East Asian (EAS)
AF:
0.742
AC:
3818
AN:
5148
South Asian (SAS)
AF:
0.606
AC:
2912
AN:
4808
European-Finnish (FIN)
AF:
0.639
AC:
6755
AN:
10566
Middle Eastern (MID)
AF:
0.654
AC:
191
AN:
292
European-Non Finnish (NFE)
AF:
0.717
AC:
48735
AN:
67976
Other (OTH)
AF:
0.656
AC:
1385
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1670
3339
5009
6678
8348
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
812
1624
2436
3248
4060
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.694
Hom.:
105219
Bravo
AF:
0.665
Asia WGS
AF:
0.663
AC:
2307
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Cutis laxa, autosomal dominant 3 Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal recessive complex spastic paraplegia type 9B Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary spastic paraplegia 9A Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

ALDH18A1-related de Barsy syndrome Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
7.6
DANN
Benign
0.55
PhyloP100
-0.0070
BranchPoint Hunter
2.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2275273; hg19: chr10-97397227; API